You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MLYS Sale Disclosure
Rodman David Malcom · SEC Form 4 · Filed Jul 10, 2026
Sale
Calculated transaction value
$65.78K
Rodman David Malcom Chief Medical Officer
MLYS
Transaction date
Jul 9, 2026
Public filing date
Jul 10, 2026
Filing lag
Filed 1 day later
MLYS daily price context
Close on/before transaction
$28.96
Jul 9, 2026
First close after public filing
$27.59
Jul 13, 2026
30-day return after filing
-0.76%
Through Aug 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,171 shares @ $30.3
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001672659-26-000033
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$100.52K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jul 9, 2026 | $34.74K |
| Mineralys Therapeutics, Inc. MLYS Current | Sale | Jul 9, 2026 | $65.78K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jul 9, 2026 | $0 |